Complaints Outcomes

Search

Search Results

Search Again
Pharmacist Registrant 38 (Feb 1, 2019)

 

The Inquiry Committee has removed all limits and conditions from the pharmacist registrant’s registration, pursuant to a report and recommendation from the registrant’s physician.


September 5, 2018
(Feb 1, 2019 – Limits and conditions removed)

The Inquiry Committee has reached an agreement with the pharmacist registrant to amend one of the terms in his Agreement of August 2, 2018. While the pharmacist registrant is still limited to working in a pharmacy for no more than four hours a day, he can now work up to eight hours up to two days per week, if necessary to ensure sufficient pharmacist staff levels.


August 2, 2018
(September 5, 2018 - Limits and Conditions Updated)

The Inquiry Committee, pursuant to s. 32.2(4)(b)(i) of the Health Professions Act, has reached an agreement with the pharmacist registrant to place limits and conditions on his pharmacy practice, pending further disposition of the Inquiry Committee. The pharmacist registrant will be limited to working in a pharmacy for no more than four hours a day and must work with another pharmacy staff member at all times. The Inquiry Committee considers this agreement necessary to protect the public. The pharmacist registrant’s name has been withheld pursuant to s. 39.3(4) of the Health Professions Act.

Yang, Hao (“David”) (Jan 29, 2019)
  1. Nature of Action: The Inquiry Committee of the College of Pharmacists of British Columbia (the “College”) conducted an investigation into the practice of Hao “David” Yang (the “Registrant”), pursuant to section 33(4) of the Health Professions Act, R.S.B.C. 1996, c. 183. The Inquiry Committee and the Registrant have agreed to resolve all matters arising from the investigation by way of a Consent Agreement under section 36(1) of the Health Professions Act.

  2. Effective date: January 29, 2019

  3. Name of registrant: Hao “David” Yang

  4. Admissions and Acknowledgements:

    On April 12, 2018, the Registrant was issued a Violation Ticket for contravening s. 77(1)(c) of the Liquor Control and Licensing Act, in that he allowed three females under the age of majority to consume or possess liquor in or at a place under his control (a hotel room booked under his name). The Registrant admitted that he knew the three females were not yet 19 and that he bought and supplied some of the alcohol found in the hotel room.

  5. Disposition:

    The Registrant entered into a Consent Agreement with the College’s Inquiry Committee, wherein the Registrant consented to the following terms:

    1. To suspend his registration as a pharmacist for a total of 14 days, commencing January 31, 2019;

    2. To successfully complete and pass an ethics course for healthcare professionals; and
       
    3. To have a Letter of Reprimand placed permanently on his registration record.
       
  6. Rationale:

    The Inquiry Committee considered that in this case, the Registrant did not act conscientiously, ethically, or with integrity. Rather, he participated in and condoned unethical and illegal behavior, in contravention of standards in the Code of Ethics. His actions could undermine patient trust in registrants and society’s trust in the pharmacy profession.

    The Inquiry Committee therefore considered the Registrant’s conduct to be serious, and that the Registrant required both remediation and deterrence in order to come into compliance. The Inquiry Committee considered the terms of the Consent Agreement necessary to protect the public, as well as send a clear message of deterrence to the profession.

Ito, Yoshitomo (Jan 24, 2019)
  1. Nature of Action: The Inquiry Committee of the College of Pharmacists of British Columbia (the “College”) conducted an investigation into the practice of Yoshitomo Ito (the “Registrant”), pursuant to section 33(4) of the Health Professions Act, R.S.B.C. 1996, c. 183. The Inquiry Committee and the Registrant have agreed to resolve all matters arising from the investigation by way of a Consent Agreement under section 36(1) of the Health Professions Act.

  2. Effective date: January 24, 2019

  3. Name of registrant: Yoshitomo Ito

  4. Location of Practice: Victoria, BC

  5. Admissions and Acknowledgements:

    Between April 2013 and December 2017, the Registrant falsified prescriptions for 18 individuals, including himself. These falsified prescriptions resulted in 208 transactions processed on PharmaNet, all which were for medications that required an authorized prescription. The majority of medications involved were controlled medications.

    The Registrant used the names and forged the signatures of eight different physicians as prescribers on these prescriptions, all without the knowledge, consent, and/or authorization of these physicians.

    In addition to billing PharmaCare for these transactions, the Registrant also billed third party insurance plans for payment of the transactions, which he knew to be false or misleading claims.

  6. Disposition:

    The Registrant entered into a Consent Agreement with the College’s Inquiry Committee, wherein the Registrant consented to terms that include (but not limited to) the following:

    1. To suspend his registration as a pharmacist for a total of 180 days;

    2. To not be a pharmacy manager and/or director of a pharmacy, and a preceptor for pharmacy students for period of five years from the date that his suspension ends;
       
    3. In relation to narcotic and controlled drugs, to not place and receive orders, and to not have signing authority relating to the ordering of such substances for a period of five years from the date that his suspension ends;

    4. To successfully complete and pass an ethics course for healthcare professionals;
       
    5. To pay a $2000.00 fine; 
       
    6. To appear before the Inquiry Committee for a verbal reprimand; and
       
    7. To write letters of apology to persons affected by his conduct. 
       
  7. Rationale:

    The Inquiry Committee considered that in this case, in addition to the serious misconduct, the Registrant placed himself and others at significant risk of harm when he provided unauthorized medications for personal use, inappropriately used personal information, and created inaccurate PharmaNet records. His actions were a serious contravention of standards in the Code of Ethics, and compromised the public’s trust in the pharmacy profession as a whole.

    The Inquiry Committee therefore determined that the Registrant required serious remediation and deterrence regarding his conduct. After also considering mitigating factors, the Inquiry Committee considered the terms of the Consent Agreement appropriate to protect the public, as well as send a clear message of deterrence to the profession.

Zanotto , Aaron Ariel Glaser (Jan 23, 2019)

The Inquiry Committee has reviewed subsequent information and determined that the extraordinary suspension imposed on the registration of Aaron Ariel Glaser Zanotto pending completion of an investigation is no longer necessary to protect the public.  Therefore, pursuant to s. 35(4) of the Health Professions Act, on January 23, 2019 the Inquiry Committee cancelled the extraordinary suspension of the registration of Mr. Zanotto. Mr. Zanotto is now able to practice pharmacy in the province of British Columbia without any limits or conditions. 


July 20, 2018
(January 23, 2019 - Registration Reinstated)

Pursuant to section 35(1)(b) of the Health Professions Act, effective July 20, 2018, the Inquiry Committee has directed an extraordinary suspension of the registration of registrant Aaron Ariel Glaser Zanotto pending completion of an investigation. The registrant will not be able to practice pharmacy in the province of British Columbia while his registration is suspended. The Inquiry Committee considered the extraordinary suspension necessary to protect the public.

While practicing as a pharmacist, the registrant allegedly made online postings, the contents of which may be regarded as reflecting harm and a risk to the public.

Note: Suspensions ordered by the Inquiry Committee under section 35(1)(b) of the Health Professions Act are made to protect the public during an investigation or pending a hearing of the Discipline Committee. Orders made under this section relate to matters which are and remain unproven unless admitted by a registrant or determined by the Discipline Committee.

Pharmacist Registrant 39 (Dec 19, 2018)

The Inquiry Committee has reinstated pharmacist registrant’s registration which had previously been suspended for an indefinite period on September 24, 2018. Pursuant to section 32.2(4)(b)(i) of the Health Professions Act, the Inquiry Committee has reached an Agreement with the pharmacist registrant whereby the registrant consented to undertakings. The undertakings include, but are not limited to:

  1. The registrant will comply with any and all recommendations and treatment prescribed or directed by her current physicians;
  2. The registrant undertakes to adhere to her routine medical monitoring program with the institution currently involved in her case and remain on the monitoring program for a minimum of 36 consecutive months of uninterrupted and verified abstinence and compliance from the day she returns to active employment as a pharmacist;
  3. In the event of any interruption to the agreed monitoring schedule set out by her medical monitoring program, the registrant will advise the College of the interruption as soon as possible and provide an explanation for the interruption;
  4. The registrant will not have access whatsoever, on or off-duty, to the narcotic safe in any pharmacy for at least one year from the date she returns to work;
  5. The registrant will not be involved in any way with ordering mood altering drugs (narcotics, opiates, opioids, benzodiazepines, and atypical sedatives such as zopiclone, zaleplon, and zolpidem and prescription psychostimulants such as dextroamphetamine, methylphenidate and modafinil), except for signing off on the necessary paperwork in the presence of a witnessing pharmacy staff member for the purposes of receiving and stocking such narcotics for at least one year from the date she returns to work;
  6. The registrant will not handle or physically prepare or dispense prescriptions for mood altering drugs (narcotics, opiates, opioids, benzodiazepines, and atypical sedatives such as zopiclone, zaleplon, and zolpidem and prescription psychostimulants such as dextroamphetamine, methylphenidate and modafinil), except if from time to time this is not possible, then she can only hand them to the patient and provide patient counselling for at least one year from the date she returns to work;
  7. The registrant will not dispose or deal with wastage or breakage of or otherwise handle any mood altering drugs (narcotics, opiates, opioids, benzodiazepines, and atypical sedatives such as zopiclone, zaleplon, and zolpidem and prescription psychostimulants such as dextroamphetamine, methylphenidate and modafinil) for at least one year from the date she returns to work;
  8. The registrant will not dispense her own medications;
  9. Prior to the commencement of employment at any pharmacy, the registrant shall disclose to the pharmacy manager and/or employer the limits and conditions on her license pursuant to this Consent Agreement if the pharmacy dispenses mood altering drugs (narcotics, opiates, opioids, benzodiazepines, and atypical sedatives such as zopiclone, zaleplon, and zolpidem and prescription psychostimulants such as dextroamphetamine, methylphenidate and modafinil);
  10. The registrant will ensure that any pharmacy manager and/or employer with whom the registrant secures employment in a pharmacy that dispenses mood altering drugs (narcotics, opiates, opioids, benzodiazepines, and atypical sedatives such as zopiclone, zaleplon, and zolpidem and prescription psychostimulants such as dextroamphetamine, methylphenidate and modafinil), submits a written statement to the College declaring their awareness of the registrant’s medical condition and the Agreement. This statement must be received within 48 hours of securing employment and/or within 48 hours of any change of pharmacy manager at the registrant’s place of employment;
  11. The registrant will inform the College in writing, via e-mail, of her places of employment as a pharmacist and report any changes to the location of her employment within 48 hours of such change. A reportable change to the registrant’s place of employment contemplates both commencement and termination of employment;
  12. The registrant will be restricted from acting in the following roles in her practice:
    1. Be a manager of a pharmacy;
    2. Be a director of a corporation that owns a pharmacy; and
    3. Act as a preceptor of pharmacy students and/or international pharmacy graduates.

This Agreement will remain in place until such time as the registrant’s physician states otherwise. The name of the registrant has been withheld in accordance with section 39.3(4)(a) of the Health Professions Act for the purposes of not identifying the personal health information of the registrant. The Inquiry Committee is satisfied that the undertakings will protect the public.


September 24, 2018
(December 19, 2018 - Registration Reinstated) 

The Inquiry Committee, pursuant to section 32.2(4)(b)(ii) of the Health Professions Act, has reached an agreement with the pharmacist registrant to voluntarily suspend her registration as a pharmacist effective September 24, 2018.  The agreement remains in effect until further notice.  The Inquiry Committee considers the agreement necessary to protect the public.  The pharmacist registrant’s name has been withheld pursuant to section 39.3(4)(a) of the Health Professions Act.

Kim, Daniel HeeJae (Dec 18, 2018)
  1. Nature of Action: The Inquiry Committee of the College of Pharmacists of British Columbia (the “College”) conducted an investigation into the practice of Daniel HeeJae Kim (the “Registrant”), pursuant to section 33(4) of the Health Professions Act, R.S.B.C. 1996, c. 183.

    The Inquiry Committee and the Registrant have agreed to resolve all matters arising from the investigation by way of a Consent Agreement under section 36(1) of the Health Professions Act.

  2. Effective date: December 18, 2018

  3. Name of registrant: Daniel HeeJae Kim

  4. Location of Practice: Vancouver, BC

  5. Admissions and Acknowledgements:

    Between January 1, 2014 and November 5, 2017, over 15,000 transactions for over-the-counter (“OTC”) and/or vitamin products were processed on a daily or weekly basis on the PharmaNet records of seven individuals. These seven individuals were not prescribed and had not received any of the OTC and/or vitamin products processed on their PharmaNet records, and had not consented to having these transactions on their PharmaNet records.

    These transactions all originated from a pharmacy where the Registrant had worked as a full-time pharmacist.

    The pharmacy’s manager at the time had directed pharmacy assistants to process these transactions on PharmaNet every Sunday in order to artificially inflate the pharmacy’s prescription count. The pharmacy assistants used the registration numbers of various pharmacist registrants as the dispensing pharmacist and/or prescriber for each transaction, without the consent and knowledge of these pharmacist registrants.

    The Registrant has admitted and/or acknowledged the following:

    1. He was aware that the pharmacy’s manager directed the processing of the transactions in order to artificially inflate the pharmacy’s prescription count;
       
    2. When he had been the pharmacist on duty, he did not directly supervise the activities of the pharmacy assistants that had processed the transactions on Sundays;
       
    3. He knew, or should have known, that:
      1. The processing of the transactions was an improper use and access of personal information;
         
      2. There was no patient consent to process the transactions;
         
      3. Pharmacy assistants are always to be directly supervised; and
         
      4. Pharmacists must personally review the PharmaNet record for all prescriptions processed;
         
    4. Even though he knew about these transactions, he did not, at any time, make a report to the College about them.
       
  6. Disposition:

    The Registrant entered into a Consent Agreement with the College’s Inquiry Committee, wherein the Registrant consented to the following terms:

    1. To suspend his registration as a pharmacist for a total of 60 days, commencing January 11, 2019;
       
    2. To successfully pass the College’s Jurisprudence Exam;
       
    3. To successfully complete and pass an ethics course for healthcare professionals;
       
    4. To successfully complete and pass the “BC Community Pharmacy Manager Training Program” offered by the British Columbia Pharmacy Association;
       
    5. To appear before the Inquiry Committee for a verbal reprimand; and
       
    6. To have a Letter of Reprimand placed permanently on his registration record.

     

  7. Rationale:

    The Inquiry Committee was concerned that the Registrant did not take personal accountability and “turned a blind eye” to the improper practices for which he was aware, enabling the improper practices to continue for over three years. While the Registrant did not stand to gain financially from what occurred, it was his professional responsibility, to the public as well as the profession, to ensure that practice and ethical standards were being met at all times while on duty. As a member of a professional body, registrants are responsible not only for their own actions, but are accountable for others in the workplace when they know, or ought to know, that inappropriate practices were occurring and ongoing. His actions, or lack thereof, were contraventions of legislation involving protection of personal information and supervision of pharmacy assistants, He also contravened standards of the Code of Ethics involving protecting and promoting the well-being of patients, benefitting society, and committing to personal and professional integrity.

    The Inquiry Committee also considered that the Registrant had previously consented to remedial undertakings to fully comply with ethical requirements, and he had breached these undertakings for this current matter. The Inquiry Committee therefore considered the Registrant’s conduct to be serious, and that the Registrant required significant remediation and deterrence in order to come into compliance.

    The Inquiry Committee considered the terms of the Consent Agreement necessary to protect the public, as well as send a clear message of deterrence to the profession. Inappropriate access of personal health information, without consent, compromises the public’s trust in the pharmacy profession as a whole. At all times, registrants must uphold legislative requirements and ethical obligations to protect personal health information.

Shareei, Mostafa (Dec 13, 2018)
  1. Nature of Action: The Inquiry Committee of the College of Pharmacists of British Columbia (“CPBC”) conducted an investigation into the practice of Mostafa Shareei (the “Registrant”), pursuant to section 33(4) of the Health Professions Act, R.S.B.C. 1996, c. 183.

The Inquiry Committee and the Registrant have agreed to resolve all matters arising from the investigation by way of a Consent Agreement under section 36(1) of the Health Professions Act.

  1. Effective date: December 13, 2018
  1. Name of registrant: Mostafa Shareei
  1. Location of Practice: Vancouver, BC
  1. Admissions and Acknowledgements:

Between July 20, 2016 and December 22, 2016, while he was owner, manager and pharmacist, several pharmacy practice deficiencies were identified.

The Registrant has admitted and/or acknowledged the following:

  1. He provided cash incentives in exchange for daily dispense prescriptions;
  2. He was aware and allowed the pharmacy to operate without a pharmacist present;
  3. He allowed non-pharmacist staff to provide methadone for witness ingestion to patients;
  4. He knew or should have known that a pharmacist/patient consultation was required for new and refill daily dispense prescriptions;
  5. He entered and did not reverse daily dispense prescriptions on PharmaNet when the patient did not attend the pharmacy;
  6. He dispensed prescriptions contrary to the prescriber’s instructions (by providing missed doses and advancing doses for a prescription that was required to be daily dispensed);
  7. He backdated prescriptions on PharmaNet (meaning that dispensing records for these prescriptions were created on dates later than the dates on which the drugs in questions were actually dispensed);
  8. He dispensed prescriptions without prescription labels; and
  9. He provided a Schedule I drug without a prescription.   
  1. Disposition:

The Registrant entered into a Consent Agreement with the Inquiry Committee of CPBC, wherein the Registrant consented to the following terms (in part):

  1. To suspend his registration as a pharmacist for 180 consecutive days commencing January 4, 2019.
  2. To not be a pharmacy manager, director, owner (direct or indirect), shareholder in a corporation that owns a pharmacy and preceptor for a period of five years from the date that his suspension ends;
  3. At his own costs, to complete and pass an ethics course for healthcare professionals;
  4. To pay a $15,000.00 fine; and
  5. To have a Letter of Reprimand placed on his registration record.
  1. Rationale:

The Inquiry Committee determined that the Registrant’s conduct raised serious concerns about his ethical and professional standards in the course of his practice at the pharmacy as a pharmacist, pharmacy manager and owner. Although this was the Registrant’s first encounter with the Inquiry Committee, they determined that his poor standard of practice warranted limits and conditions imposed on his licence, in addition to a fine and a requirement to take an ethics course in order to come into compliance.

The Inquiry Committee considered the terms of the Consent Agreement necessary to protect the public, as well as send a clear message of deterrence to the profession. 

Mai , Ha Van Phan (Dec 3, 2018)
  1. Nature of Action: The Inquiry Committee of the College of Pharmacists of British Columbia (the “College”) conducted an investigation into the practice of Ha Van Phan Mai (the “Registrant”), pursuant to section 33(4) of the Health Professions Act, R.S.B.C. 1996, c. 183.

The Inquiry Committee and the Registrant have agreed to resolve all matters arising from the investigation by way of a Consent Agreement under section 36(1) of the Health Professions Act.

  1. Effective date: December 3, 2018
  1. Name of registrant: Ha Van Phan Mai
  1. Location of Practice: Vancouver, BC
  1. Admissions and Acknowledgements:

Between January 1, 2014 and November 5, 2017, over 15,000 transactions for over-the-counter (“OTC”) and/or vitamin products were processed on a daily or weekly basis on the PharmaNet records of seven individuals. These seven individuals were not prescribed and had not received any of the OTC and/or vitamin products processed on their PharmaNet records, and had not consented to having these transactions on their PharmaNet records.

These transactions all originated from a pharmacy where the Registrant had worked as a full-time pharmacist.

The pharmacy’s manager at the time had directed pharmacy assistants to process these transactions on PharmaNet every Sunday in order to artificially inflate the pharmacy’s prescription count. The pharmacy assistants used the registration numbers of various pharmacist registrants as the dispensing pharmacist and/or prescriber for each transaction, without the consent and knowledge of these pharmacist registrants.

The Registrant has admitted and/or acknowledged the following:

  1. She was aware that the pharmacy’s manager directed the processing of the transactions in order to artificially inflate the pharmacy’s prescription count;
     
  2. When she had been the pharmacist on duty, she did not directly supervise the activities of the pharmacy assistants that had processed the transactions on Sundays;
     
  3. She knew, or should have known, that:
    1. The processing of the transactions was an improper use and access of personal information;
       
    2. There was no patient consent to process the transactions;
       
    3. Pharmacy assistants are always to be directly supervised; and
       
    4. Pharmacists must personally review the PharmaNet record for all prescriptions processed;
       
  4. Even though she knew about these transactions, she did not, at any time, make a report to the College about them.
  1. Disposition:

The Registrant entered into a Consent Agreement with the College’s Inquiry Committee, wherein the Registrant consented to the following terms

  1. To successfully complete and pass an ethics course for healthcare professionals within six months. If she fails to complete this within the specified time period, her registration will be suspended for a period of 30 days;
     
  2. To successfully pass the College’s Jurisprudence Exam;
     
  3. To successfully complete and pass the “BC Community Pharmacy Manager Training Program” offered by the British Columbia Pharmacy Association; and
     
  4. To have a Letter of Reprimand placed permanently on her registration record.
  1. Rationale:

The Inquiry Committee was concerned that the Registrant did not take personal accountability and “turned a blind eye” to the improper practices for which she was aware, enabling the improper practices to continue for over three years. While the Registrant did not stand to gain financially from what occurred, it was her professional responsibility, to the public as well as the profession, to ensure that practice and ethical standards were being met at all times while on duty. As a member of a professional body, registrants are responsible not only for their own actions, but are accountable for others in the workplace when they know, or ought to know, that inappropriate practices were occurring and ongoing. Her actions, or lack thereof, were contraventions of legislation involving protection of personal information and supervision of pharmacy assistants, She also contravened standards of the Code of Ethics involving protecting and promoting the well-being of patients, benefitting society, and committing to personal and professional integrity.

The Inquiry Committee considered the terms of the Consent Agreement necessary to protect the public, as well as send a clear message of deterrence to the profession. Inappropriate access of personal health information, without consent, compromises the public’s trust in the pharmacy profession as a whole. At all times, registrants must uphold legislative requirements and ethical obligations to protect personal health information.

Lu, William Wanyang (Nov 30, 2018)
  1. Nature of Action: The Inquiry Committee of the College of Pharmacists of British Columbia (the “College”) conducted an investigation into the practice of William Wanyang Lu (the “Registrant”), pursuant to section 33(4) of the Health Professions Act, R.S.B.C. 1996, c. 183.

The Inquiry Committee and the Registrant have agreed to resolve all matters arising from the investigation by way of a Consent Agreement under section 36(1) of the Health Professions Act.

  1. Effective date: November 30, 2018
  1. Name of registrant: William Wanyang Lu
  1. Location of Practice: Vancouver, BC
  1. Admissions and Acknowledgements:

Between January 1, 2014 and November 5, 2017, over 15,000 transactions for over-the-counter (“OTC”) and/or vitamin products were processed on a daily or weekly basis on the PharmaNet records of seven individuals. These seven individuals were not prescribed and had not received any of the OTC and/or vitamin products processed on their PharmaNet records, and had not consented to having these transactions on their PharmaNet records.

These transactions all originated from a pharmacy where the Registrant had worked as a full-time pharmacist.

The pharmacy’s manager at the time had directed pharmacy assistants to process these transactions on PharmaNet every Sunday in order to artificially inflate the pharmacy’s prescription count. The pharmacy assistants used the registration numbers of various pharmacist registrants as the dispensing pharmacist and/or prescriber for each transaction, without the consent and knowledge of these pharmacist registrants.

The Registrant has admitted and/or acknowledged the following:

  1. He was aware that the pharmacy’s manager directed the processing of the transactions in order to artificially inflate the pharmacy’s prescription count;
     
  2. When he had been the pharmacist on duty, he did not directly supervise the activities of the pharmacy assistants that had processed the transactions on Sundays;
     
  3. He knew, or should have known, that:
    1. The processing of the transactions was an improper use and access of personal information;
       
    2. There was no patient consent to process the transactions;
       
    3. Pharmacy assistants are always to be directly supervised; and
       
    4. Pharmacists must personally review the PharmaNet record for all prescriptions processed;
       
  4. Even though he knew about these transactions, he did not, at any time, make a report to the College about them.
  1. Disposition:

The Registrant entered into a Consent Agreement with the College’s Inquiry Committee, wherein the Registrant consented to the following terms:

  1. To successfully complete and pass an ethics course for healthcare professionals within six months. If he fails to complete this within the specified time period, his registration will be suspended for a period of 30 days;
     
  2. To successfully pass the College’s Jurisprudence Exam;
     
  3. To successfully complete and pass the “BC Community Pharmacy Manager Training Program” offered by the British Columbia Pharmacy Association; and
     
  4. To have a Letter of Reprimand placed permanently on his registration record.
  1. Rationale:

The Inquiry Committee was concerned that the Registrant did not take personal accountability and “turned a blind eye” to the improper practices for which he was aware, enabling the improper practices to continue for over three years. While the Registrant did not stand to gain financially from what occurred, it was his professional responsibility, to the public as well as the profession, to ensure that practice and ethical standards were being met at all times while on duty. As a member of a professional body, registrants are responsible not only for their own actions, but are accountable for others in the workplace when they know, or ought to know, that inappropriate practices were occurring and ongoing. His actions, or lack thereof, were contraventions of legislation involving protection of personal information and supervision of pharmacy assistants, He also contravened standards of the Code of Ethics involving protecting and promoting the well-being of patients, benefitting society, and committing to personal and professional integrity.

The Inquiry Committee considered the terms of the Consent Agreement necessary to protect the public, as well as send a clear message of deterrence to the profession. Inappropriate access of personal health information, without consent, compromises the public’s trust in the pharmacy profession as a whole. At all times, registrants must uphold legislative requirements and ethical obligations to protect personal health information.

Wong, Jason Jonathan (Nov 27, 2018)
  1. Nature of Action: The Inquiry Committee of the College of Pharmacists of British Columbia (the “College”) conducted an investigation into the practice of Jason Jonathan Wong (the “Registrant”), pursuant to section 33(4) of the Health Professions Act, R.S.B.C. 1996, c. 183.

    The Inquiry Committee and the Registrant have agreed to resolve all matters arising from the investigation by way of a Consent Agreement under section 36(1) of the Health Professions Act.

  2. Effective date: November 27, 2018

  3. Name of registrant: Jason Jonathan Wong

  4. Location of Practice: Port Coquitlam, BC

  5. Admissions and Acknowledgements:

    Between January 1, 2014 and November 5, 2017, over 15,000 transactions for over-the-counter (“OTC”) and/or vitamin products were processed on a daily or weekly basis on the PharmaNet records of seven individuals. These seven individuals were not prescribed and had not received any of the OTC and/or vitamin products processed on their PharmaNet records, and had not consented to having these transactions on their PharmaNet records.

    These transactions all originated from a pharmacy where the Registrant had worked as a full-time pharmacist.

    The pharmacy’s manager at the time had directed pharmacy assistants to process these transactions on PharmaNet every Sunday in order to artificially inflate the pharmacy’s prescription count. The pharmacy assistants used the registration numbers of various pharmacist registrants as the dispensing pharmacist and/or prescriber for each transaction, without the consent and knowledge of these pharmacist registrants.

    The Registrant has admitted and/or acknowledged the following:

    1. He was aware that the pharmacy’s manager directed the processing of the transactions in order to artificially inflate the pharmacy’s prescription count;
       
    2. When he had been the pharmacist on duty, he did not directly supervise the activities of the pharmacy assistants that had processed the transactions on Sundays;
       
    3. He knew, or should have known, that:
      1. The processing of the transactions was an improper use and access of personal information;
         
      2. There was no patient consent to process the transactions;
         
      3. Pharmacy assistants are always to be directly supervised; and
         
      4. Pharmacists must personally review the PharmaNet record for all prescriptions processed;
         
    4. Even though he knew about these transactions, he did not, at any time, make a report to the College about them.
       
  6. Disposition:

    The Registrant entered into a Consent Agreement with the College’s Inquiry Committee, wherein the Registrant consented to the following terms:

    1. To suspend his registration as a pharmacist for a total of 60 days, commencing November 27, 2018;
       
    2. To successfully pass the College’s Jurisprudence Exam;
       
    3. To successfully complete and pass an ethics course for healthcare professionals;
       
    4. To successfully complete and pass the “BC Community Pharmacy Manager Training Program” offered by the British Columbia Pharmacy Association;
       
    5. To appear before the Inquiry Committee for a verbal reprimand; and
       
    6. To have a Letter of Reprimand placed permanently on his registration record.

     

  7. Rationale:

    The Inquiry Committee was concerned that the Registrant did not take personal accountability and “turned a blind eye” to the improper practices for which he was aware, enabling the improper practices to continue for over three years. While the Registrant did not stand to gain financially from what occurred, it was his professional responsibility, to the public as well as the profession, to ensure that practice and ethical standards were being met at all times while on duty. As a member of a professional body, registrants are responsible not only for their own actions, but are accountable for others in the workplace when they know, or ought to know, that inappropriate practices were occurring and ongoing. His actions, or lack thereof, were contraventions of legislation involving protection of personal information and supervision of pharmacy assistants, He also contravened standards of the Code of Ethics involving protecting and promoting the well-being of patients, benefitting society, and committing to personal and professional integrity.

    The Inquiry Committee also considered that the Registrant had previously consented to remedial undertakings to fully comply with ethical requirements, and he had breached these undertakings for this current matter. The Inquiry Committee therefore considered the Registrant’s conduct to be serious, and that the Registrant required significant remediation and deterrence in order to come into compliance.

    The Inquiry Committee considered the terms of the Consent Agreement necessary to protect the public, as well as send a clear message of deterrence to the profession. Inappropriate access of personal health information, without consent, compromises the public’s trust in the pharmacy profession as a whole. At all times, registrants must uphold legislative requirements and ethical obligations to protect personal health information.

Pages